Orthofix International | OFIX - Interest Expense On Debt


Orthofix International reported 5.2M in Interest Expense on Debt for its fiscal quarter ending in September of 2024.





Interest Expense On Debt Change Date
Accuray USD 2.88M 72K Dec/2024
AngioDynamics USD 100K 134K Feb/2025
Artivion USD 7.83M 1.22M Mar/2024
AtriCure USD 1.33M 17K Sep/2025
Dexcom USD 4.7M 0 Sep/2025
EDAP TMS EUR 49K 8K Sep/2025
Globus Medical USD 17K 5.1B Dec/2025
Hologic USD 27.6M 1000K Dec/2025
Inogen 1.03M 384K Mar/2025
Insulet USD 9.2M 2.2M Dec/2025
Integra LifeSciences USD 23.67M 953K Dec/2025
J&J USD 18M 290M Sep/2025
Medtronic USD 181M 0 Dec/2025
Mesa Laboratories USD 3.02M 180K Sep/2024
Orthofix International 5.2M 4.71M Sep/2024
Smith & Nephew USD 69M 1000K Dec/2025
STAAR Surgical USD 800K 799K Sep/2025
Stryker USD 157M 46.17B Sep/2025
Surmodics USD 884K 5K Sep/2024
Tandem Diabetes Care USD 2.07M 872.58M Dec/2025
Teleflex USD 28.15M 3.69M Dec/2025
Veracyte USD 2K 1000 Dec/2023
Zimmer Biomet Holdings USD 71.9M 3.5M Dec/2025